Related Experiment Video
Updated: Jun 5, 2026

Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Intravenous colistin administration in neonates
Mamta Jajoo1, Vishal Kumar, Manish Jain
1Department of Pediatrics, Maulana Azad Medical College & Associated Chacha Nehru Bal Chikitsalaya, New Delhi, India.
Intravenous colistin (colistimethate) is safe and effective for treating multidrug-resistant Gram-negative infections in critically ill neonates. This study shows favorable outcomes in sepsis, pneumonia, and meningitis cases.
Area of Science:
- Neonatal Intensive Care
- Infectious Diseases
- Pharmacology
Background:
- Nosocomial infections caused by multidrug-resistant Gram-negative pathogens pose a significant challenge in intensive care units.
- Parenteral colistin use has resurged, but safety and efficacy data in neonates are limited.
- This study addresses the need for data on intravenous colistin (colistimethate) in critically ill neonates.
Purpose of the Study:
- To evaluate the efficacy and safety of intravenous colistimethate in treating sepsis in critically ill term and preterm neonates.
- To assess the clinical outcomes and microbiological clearance in neonates receiving colistimethate.
- To identify potential adverse events associated with colistimethate use in this population.
Main Methods:
- Retrospective review of neonates treated with colistimethate in a tertiary care neonatal intensive care unit from January 2009 to December 2009.
- Analysis of treatment courses, dosages, pathogen profiles, and clinical outcomes.
- Evaluation of microbiological clearance and adverse events, including renal function.
Main Results:
- Eighteen neonates received 21 courses of colistimethate for various infections, including pneumonia, bloodstream infections, and meningitis.
- Common pathogens included Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
- A favorable clinical outcome was observed in 76% of courses, with microbiological clearance in 17 courses. Two neonates experienced increased serum creatinine.
Conclusions:
- Intravenous colistimethate demonstrates safety and efficacy in treating multidrug-resistant Gram-negative infections in neonates.
- The findings support the use of colistimethate in preterm and extremely low birth weight neonates.
- Further research may be warranted to optimize dosing and monitor for potential adverse effects.
Related Concept Videos
Drug Dosing: Infants and Children
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Urinary Tract Infection IV: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Endocarditis IV: Nursing Management

